Pimozide, a specific USP1 inhibitor, blocks glioma stem cell maintenance and radio resistance [48], However, as nonspecific DUB inhibitors, these broad-spectrum inhibitors may amplify their biological effects and non-specific toxicity, so it is still recommended to use specific DUB inhibitors in clinical practice. The gene discussed is ZUP1; the disease is glioma.